Literature DB >> 19559007

Attenuation of LPS-induced iNOS expression by 1,5-anhydro-d-fructose.

Xiaojie Meng1, Ko-ichi Kawahara, Kenji Matsushita, Yuko Nawa, Binita Shrestha, Kiyoshi Kikuchi, Hisayo Sameshima, Teruto Hashiguchi, Ikuro Maruyama.   

Abstract

1,5-anhydro-d-fructose (1,5-AF), a monosaccharide formed from starch and glycogen, exhibits antioxidant and antibacterial activity, and inhibits cytokine release by attenuating NF-kappaB activation in LPS-stimulated mice. The present study examined whether 1,5-AF inhibits lipopolysaccharide (LPS)-induced inducible nitric oxide synthase (iNOS) in vitro and in vivo. We found that 1,5-AF significantly blocked the production of NO, and protein and mRNA expression of iNOS, and up-regulated IL-10 production in vitro. We also investigated the effects of 1,5-AF on acute lung inflammation in C57BL/6J mice. We found that protein and mRNA expression of iNOS in lung tissues were inhibited by 1,5-AF pretreatment. In addition, the serum level of IL-10 was upregulated by 1,5-AF. Collectively, the iNOS transcriptional and translational inhibitory effects of 1,5-AF seem to be prolonged and enhanced by the production of IL-10. These results suggest that 1,5-AF could be a useful adjunct in the treatment of acute lung inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559007     DOI: 10.1016/j.bbrc.2009.06.108

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  1,5-Anhydro-D-fructose: A natural antibiotic that inhibits the growth of gram-positive bacteria and microbial biofilm formation to prevent nosocomial infection.

Authors:  Xiaojie Meng; Ko-Ichi Kawahara; Hiroaki Miyanohara; Yasushi Yoshimoto; Kazuhiro Yoshinaga; Satoshi Noma; Kiyoshi Kikuchi; Yoko Morimoto; Takashi Ito; Yoko Oyama; Narimasa Yoshinaga; Binita Shrestha; Binita Chandan; Kentaro Mera; Ko-Ichi Tada; Naoki Miura; Yoshiko Ono; Kazunori Takenouchi; Ryuichi Maenosono; Tomoka Nagasato; Teruto Hashiguchi; Ikuro Maruyama
Journal:  Exp Ther Med       Date:  2011-04-01       Impact factor: 2.447

2.  Gut Microbiota Protected Against pseudomonas aeruginosa Pneumonia via Restoring Treg/Th17 Balance and Metabolism.

Authors:  Long Wen; Lei Shi; Xiang-Long Kong; Ke-Yu Li; Hui Li; Di-Xuan Jiang; Fan Zhang; Zhi-Guo Zhou
Journal:  Front Cell Infect Microbiol       Date:  2022-06-16       Impact factor: 6.073

3.  Anti-Inflammatory Effect of Mangostenone F in Lipopolysaccharide-Stimulated RAW264.7 Macrophages by Suppressing NF-κB and MAPK Activation.

Authors:  Byoung Ok Cho; Hyung Won Ryu; Yangkang So; Chang Wook Lee; Chang Hyun Jin; Hong Sun Yook; Yong Wook Jeong; Jong Chun Park; Il Yun Jeong
Journal:  Biomol Ther (Seoul)       Date:  2014-07       Impact factor: 4.634

4.  A Possibility of Simultaneous Treatment with the Multicomponent Drug, Ninjin'yoeito, for Anorexia, Apathy, and Cognitive Dysfunction in Frail Alzheimer's Disease Patients: An Open-Label Pilot Study.

Authors:  Makoto Ohsawa; Yukiko Tanaka; Yoshito Ehara; Setsuko Makita; Kosuke Onaka
Journal:  J Alzheimers Dis Rep       Date:  2017-12-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.